TrialReader


Effect of Dietary Sodium and Potassium Citrate on Renal Mineral Handling

NCT03281928 — Not applicable, Terminated, 30 participants, University of Chicago

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  
RegistryNCT03281928
StatusTerminated - Study closed due to IRB expiration. A new protocol (IRB22-1817) was submitted to continue the research.
PhaseNot applicable
Study typeInterventional; randomized, crossover, masking: double, other
Enrollment30 (Actual)
SponsorUniversity of Chicago (Other)
ConditionsKidney Stone
InterventionsSodium and Potassium Citrate, Placebo (Dietary supplement)
Datesstart 2017-10-01, primary completion 2022-11-15, completion 2022-11-15, first posted 2017-09-13, last updated 2025-04-22
Locations1 site in United States

Related Papers Related Patents Related Grants Related Experts
AI Assistant Save
All trials for Kidney Stone All trials of Sodium and Potassium Citrate All trials of Placebo

-Summary

This study intends to characterize the affect of sodium and potassium citrate in the diet on renal function.

Expand all sections  ·  Collapse all

+Arms and interventions

ArmTypeInterventionsDescription
Low Sodium plus Potassium CitrateExperimentalDietary Supplement: Sodium and Potassium Citrate
Low Sodium plus placeboPlacebo comparatorDietary Supplement: Placebo
High Sodium plus Potassium CitrateExperimentalDietary Supplement: Sodium and Potassium Citrate
High Sodium plus placeboPlacebo comparatorDietary Supplement: Placebo
  • Sodium and Potassium Citrate (Dietary supplement): Sodium and potassium citrate levels will be altered in diet and renal mineral handling will be measured as compared to placebo.
  • Placebo (Dietary supplement): Sodium without Potassium Citrate

+Outcome measures

Primary outcomes

  • Urine Calcium levels [10 days]: Amount of calcium in the urine will be measured

+Eligibility

Sex: All, ages: 18 Years to 70 Years, accepts healthy volunteers

Inclusion Criteria:

* age 18 - 70, approximately equal numbers of men and women
* studied by endoscopy with complete papillary mapping and grading
* stone formers

Exclusion Criteria:

* Patients with primary renal diseases or renal impairment (eGFR < 90), or medical conditions such as diabetes, or systemic diseases or medications that alter calcium metabolism
* Patients with known bladder voiding problems

+Locations (1)

FacilityCityCountryStatus
University of Chicago Medical CenterChicago, IllinoisUnited States

My Notes